Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
63 Leser
Artikel bewerten:
(0)

ResMed Launches Smaller Alternative to the Full Face Mask for CPAP Treatment

OSLO, Norway, September 16, 2010 /PRNewswire/ --

- Introducing Quattro FX, ResMed increases choice and comfort for sufferers of sleep apnoea

ResMed (NYSE: RMD), a leading developer, manufacturer, and distributor of sleep and respiratory medical equipment today announced the launch of Quattro FX Full Face Mask, a smaller alternative to the full face mask for use with positive airway pressure (PAP) therapy.

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20100203/RESMEDLOGO)

A new and smaller model, Quattro FX provides an effective alternative to conventional full face masks. Only covering the patient's mouth and nose, the Quattro FX mask offers unrestricted view, giving patients a clear line of sight. New technologies incorporated in the contoured cushion membranes of the Spring Air cushion and Spring frame, enables the same level of stability and angular adjustment as provided by the forehead support of conventional full face masks. New headgear design, featuring a contoured crown strap at the top of the head, further contributes to patient comfort by avoiding the sensitive area around the neck.

The custom-made sizing tool, Swing Seal, simplifies the fitting process and increases the chances of an accurate fitting. Once fitted, convenient set-and-forget headgear clips provides easy attachment and detachment, without adjusting the headgear settings. This helps the patient achieve the right fit and secure sealing every night, enhancing patient compliance and comfort. The seal is kept safe with the Spring Air cushion which absorbs even the slightest movement.

Sleep apnoea is one of the more common, and yet highly undiagnosed, sleep disorders. Obstructive sleep apnoea (OSA) is the most common type of sleep apnoea and is marked by the collapse or obstruction of the airway during sleep. The most effective treatment is Continuous Positive Airway Pressure (CPAP) therapy. In this non-invasive treatment, air is pressurised by a small device and delivered to the airway of the patient through a mask that fits on/over the nose, or nose and mouth. The pressurised air keeps the upper airway open and helps the person to get a restful night without interruptions caused by apnoeas.

ResMed recently launched the new S9 Series featuring reduced noise, improved humidification system, and a more comfortable breathing system. The S9 Series is designed to deliver unsurpassed comfort to the patient by automatically controlling the pressure. The introduction of yet another mask for use with the S9 devices contributes to increased consumer choice for sufferers of sleep apnoea and offers the quietest mask and machine combination available on the market.

"We are extremely proud to offer more choice to those suffering from sleep apnoea and other respiratory problems by diversifying the Quattro range. This addition to the Quattro range, where we have achieved a smaller size, while at the same time maintaining the same quality as the other masks in the range, is a true innovation," added Mike McEwan, Vice President, Patient Interface, Europe at ResMed.

About ResMed

ResMed is a leading developer, manufacturer, and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. We are dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit http://www.resmed.com.

ResMed

Henrik Aase, Marketing Communications Director of ResMed - Europe, +47-67-11-88-59, mobile, +47-97-53-91-12, henrik.aase@resmed.com; or for interviews, photos, additional information, Vidar Sie of Burson-Marsteller Oslo, mobile, +47-901-68-829, vidar.sie@bm.com, for ResMed

© 2010 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.